Repros Therapeutics (RPRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $28.16 +0.97%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
